Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy for heart failure].

H Just1

  • 1just@sfa.ukl.uni-freiburg.de

Therapeutische Umschau. Revue Therapeutique
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Pharmacotherapy for congestive heart failure involves diuretics, vasodilators, neurohumoral inhibitors, and inotropic drugs to manage symptoms and improve survival. Careful drug selection and monitoring are crucial for effective heart failure management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others.

Journal of medical ethics·2008
Same author

Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation.

Heart (British Cardiac Society)·2003
Same author

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

Lancet (London, England)·2002
Same author

Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints.

Nuclear medicine communications·2002
Same author

Impact of oligomerization on the function of the human serotonin transporter.

Biochemical Society transactions·2001
Same author

[Current status of endocarditis prevention].

Zeitschrift fur Kardiologie·2001
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Congestive heart failure (CHF) management requires a multi-faceted approach.
  • Pharmacotherapy is a cornerstone of CHF treatment, addressing symptoms and prognosis.

Purpose:

  • To outline the pharmacological strategies for treating congestive heart failure.
  • To classify and describe the roles of key drug classes in CHF management.

Summary:

  • Treatment involves addressing precipitating causes, managing the failing heart with drugs, and preventing complications.
  • Key drug classes include diuretics, vasodilators, neurohumoral inhibitors (ACE inhibitors, ARBs, beta-blockers), and inotropic agents.
  • Each drug class has specific indications, benefits, and limitations, with beta-blockers and ACE inhibitors/ARBs showing significant impact on survival.

Related Experiment Videos

Impact:

  • Optimized pharmacotherapy improves patient symptoms, exercise capacity, and overall survival in congestive heart failure.
  • Understanding drug mechanisms and limitations is vital for effective clinical practice and patient outcomes.
  • Future research directions include novel inotropes, gene therapy, and modulation of the ANP system.